This fact begs the question: how are compounding pharmacies acquiring 'semaglutide'
Indications for Semaglutide While semaglutide was initially developed to treat type 2 diabetes (marketed as Ozempic), it has been shown to be effective for weight management in individuals without diabetes as well
When clinical outcomes are nearly equivalent, the critical questions become: How do we improve access, affordability, and long-term adherence
Beyond tirzepatide, other incretin-based therapies have shown promise, such as retatrutide, a novel triple-hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, with early-phase trials demonstrating profound effects on weight reduction [36]
Men who took 8g of citrulline malate before exercising performed significantly more repetitions of leg presses, leg extensions, and hack squats than their non-supplementing counterparts
10.1016/j.clinthera.2005.11.006